Filter
43
Filtered Results: 43
Text search:
fluvoxamine
Featured
Recommendations
4
New Publications
4
Language
Document type
No document type
28
Guidelines
11
Manuals
3
Studies & Reports
1
Countries / Regions
Ethiopia
3
Latin America and the Carribbean
2
South Africa
2
Singapore
1
Global
1
Authors & Publishers
Publication Years
Category
COVID-19
4
Guidelines
4
Drugs & Medical Equipment
4
Neurology & Psychology
1
Infection Control & Prevention (IPC)
1
Capacity Building
1
Toolboxes
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
13
Children/Adolescents Mental Disorders
13
Clinical Guidelines
7
Anxiety Disorders
6
Essential Medicines & Devices Lists
3
Substance Use Disorders & Addiction
3
Depression
3
Substance Use Disorders, Others
2
Country specific documents
2
Gambling
2
Mental Disorders
2
others
2
Bipolar Affective Disorders
2
Alcohol
1
Posttraumatic stress disorder Adults
1
Diagnosis & Treatment PTSD in Children
1
Training Manuals
1
IEC Material Mental Disorders
1
Mental Health Guidelines
1
Sexual Abuse
1
Essential List
1
Psychosocial Support
1
Falsified & Substandard
1
Abstract: Posttraumatic stress disorder (PTSD) is a chronic psychological disorder that can develop after exposure to a traumatic event. This review summarizes the literature on the epidemiology, assessment, and treatment of PTSD. We provide a review of the characteristics of PTSD along with associa...
The aim of this study is to research deeply on the post-traumatic stress disorder in sexually abused children. Proving the presence of forms of the disorder in children and the their treatment mode will be in the center of the study. The methods used to conduct this study will be a literature review...
Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.
The purpose of the Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care is to provide professionals with practical recommendations based on scientific evidence to assist in the detection and effective treatment of these disorders
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Mood disorders
Chapter E.1
2015 edition
Le trouble anxiété de séparation (TAS) représente environ la moitié de l’ensemble des troubles anxieux
(Cartwright-Harton et al, 2006). La plupart des troubles anxieux pédiatriques
présentent les mêmes critères diagnostics que chez l’adulte à l’exception du TAS,
actuellement class...
Introducción
Capítulo A.7
Edición en español
Editor: Juan José García-Orozco
Traducción: Juan José García-Orozco y Carlos González Vivas
Revisor de traducción: Laura Borredá Belda
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
MOH clinical practice guidelines
Updated Treatment Guidelines
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up...
26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunac...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
